Brief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
03/08/2026 14:22
BRIEF-Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies Aug 3 (Reuters) - Genprex Inc GNPX.O:
GENPREX ANNOUNCES COLLABORATION WITH ROCHE DIAGNOSTICS FOR BIOMARKER ASSAY VALIDATION STUDIES
GENPREX - EXPECTS TO COMPLETE VALIDATION STUDIES BY END OF 2026
GENPREX - COLLABORATION TO REFINE PATIENT IDENTIFICATION USING TROP2 BIOMARKER
Source text: ID:nPn1CNJkXa
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy